COA 2023: 2nd Gen Uncemented Trabecular Metal-Backed vs. Cemented Polyethylene Glenoid Components .
A Multi-Centre, Randomized Controlled Trial Comparing a Second-Generation Uncemented Trabecular Metal-backed vs Cemented Polyethylene Glenoid Component in Total Shoulder Arthroplasty: Five-Year Results
93 patients with glenohumeral osteoarthritis scheduled for a total shoulder arthroplasty were randomized to receive a second-generation uncemented trabecular metal glenoid component (n=46) or a cemented polyethylene glenoid component (n=47). The primary outcome of interest was the Western Ontario Osteoarthritis Shoulder Score (WOOS). Secondary outcomes of interest included the American Shoulder and Elbow Surgeons score, EQ5D, SF-12, clinical and radiographic exams. This was a 5-year follow-up study, previously reported at 2-years post-operation. The results found no statistically or clinically significant differences in all outcomes between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
